[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:severe-renal-impairment":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Severe Renal Impairment",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07559396","A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease",[11],"Phase 1","RECRUITING","2026-08-26T02:18:25.327036Z","2026-06-17T02:29:30.058110Z",[],[]]